Physician profile
Krishna C Murthy
NPI 1336178664
$891.87
in general payments reported to CMS, 2019-2025
14 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.04 · 2022: $19.58 · 2023: $70.96 · 2024: $282 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806 · Education: $27.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.95 |
| Education | $27.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $310.28 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $235.73 | 2023-2025 | Fasenra, Tezspire, Airsupra |
| Biocryst US Sales Co., LLC | $75.37 | 2024-2025 | Orladeyo |
| Glaxosmithkline, LLC. | $45.79 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $41.33 | 2023-2024 | |
| Organon LLC | $26.37 | 2025 | |
| Amgen INC. | $23.98 | 2025 | Tezspire |
| Csl Behring | $22.99 | 2025 | Hizentra |
| Circassia INC. | $19.61 | 2019 | |
| Boston Scientific Corporation | $19.58 | 2022 | |
| Genentech USA, INC. | $19.43 | 2019 | |
| Kaleo, INC. | $19.07 | 2024 | Auvi-Q |
| Grifols USA, LLC | $18.58 | 2024 | Xembify |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2024 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.